APA

Deininger M. W., Hodgson J. G., Shah N. P., Cortes J. E., Kim D., Nicolini F. E., Talpaz M., Baccarani M., Müller M. C., Li J., Parker W. T., Lustgarten S., Clackson T., Haluska F. G., Guilhot F., Kantarjian H. M., Soverini S., Hochhaus A., Hughes T. P., Rivera V. M. & Branford S. (20160629). Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients. : Blood.

Chicago

Deininger Michael W, Hodgson J Graeme, Shah Neil P, Cortes Jorge E, Kim Dong-Wook, Nicolini Franck E, Talpaz Moshe, Baccarani Michele, Müller Martin C, Li Jin, Parker Wendy T, Lustgarten Stephanie, Clackson Tim, Haluska Frank G, Guilhot Francois, Kantarjian Hagop M, Soverini Simona, Hochhaus Andreas, Hughes Timothy P, Rivera Victor M and Branford Susan. 20160629. Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients. : Blood.

Harvard

Deininger M. W., Hodgson J. G., Shah N. P., Cortes J. E., Kim D., Nicolini F. E., Talpaz M., Baccarani M., Müller M. C., Li J., Parker W. T., Lustgarten S., Clackson T., Haluska F. G., Guilhot F., Kantarjian H. M., Soverini S., Hochhaus A., Hughes T. P., Rivera V. M. and Branford S. (20160629). Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients. : Blood.

MLA

Deininger Michael W, Hodgson J Graeme, Shah Neil P, Cortes Jorge E, Kim Dong-Wook, Nicolini Franck E, Talpaz Moshe, Baccarani Michele, Müller Martin C, Li Jin, Parker Wendy T, Lustgarten Stephanie, Clackson Tim, Haluska Frank G, Guilhot Francois, Kantarjian Hagop M, Soverini Simona, Hochhaus Andreas, Hughes Timothy P, Rivera Victor M and Branford Susan. Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients. : Blood. 20160629.